Colin graduated as a doctor from the University of Sydney in 1976 with honours. He worked as a general practitioner for nearly 30 years, with a special interest in smoking cessation.
He has an interest in all aspects of smoking cessation and tobacco control with a special interest in tobacco harm reduction – helping smokers who can’t quit to switch to safer nicotine products.
Apart from his clinical and university work, Colin has conducted hundreds of workshops and lectures around Australia and New Zealand teaching students, medical practitioners and other health professionals how to help smokers quit.
For many years he was actively involved in researching, developing and teaching Smokescreen for the 1990s, a program developed at the University of New South Wales for use by general practitioners to help smokers quit.
Click here to see his current teaching schedule.
Colin is a strong believer in evidence-based medicine, i.e. using treatments that are proven to be effective in scientific studies. He has participated in many research studies on how to quit smoking and has published many articles in peer-reviewed medical journals. Click here to see or download some of his publications.
Colin is a member of the Smoking Cessation Guideline Expert Advisory Group that develops the RACGP Australian national smoking cessation guidelines.
He is the Founding Chairman and a Director of the Australian Tobacco Harm Reduction Association, a registered health promotion charity dedicated to raising awareness of low-risk nicotine products as a substitute for smoking for smokers who can’t quit.
He is a past Vice President of the Australian Association of Smoking Cessation Professionals, Australia’s peak body for experts in the field of smoking cessation.
He is a reviewer for a range of peer-reviewed medical journals such as the British Medical Journal, Drug and Alcohol Review, Harm Reduction Journal, MedicineToday and the prestigious Cochrane Tobacco Group.
He is on the NSW Health Advisory Committee on Electronic Cigarettes.
For 16 years, he was the editor of Your Health newsletter, a health education newsletter distributed by over 1,600 Australian GPs to their patients.
Colin is currently an investigator on 2 NHMRC-funded clinical trials at the National Drug and Alcohol Centre, University of New South Wales, Sydney.
Adding an electronic-cigarette to standard behavioural treatment for low-socioeconomic status smokers: A randomised trial
Cytisine versus varenicline for smoking cessation
I have no financial or commercial relationship with any electronic cigarette or tobacco company. Never have, never will.
I provide advice to the pharmaceutical industry and other organisations that require specialist advice in the field of smoking cessation. I have received payments for teaching, consulting and conference expenses from Pfizer Australia, GlaxoSmithKline, Johnson & Johnson Pacific and Perrigo Australia.